People, May, 2011

Mover of the month

Takeda Pharmaceutical Company has promoted Trevor Smith from vice-president of international strategy to chief executive of Takeda Pharmaceuticals Europe. Smith has worked at Takeda for more than 10 years. Before joining Takeda, he worked at Servier Laboratories.

Healthcare research agency HRW has promoted Gillian Newbold to the board of directors. She joined the company in 2009 and is currently research director (strategy).

Healthcare at Home has appointed Nigel Brooksby as a senior strategic adviser and Graeme Duncan as director of strategy, for the company's fast-growing pharmaceutical services business. Brooksby has almost 40 years' experience in the life sciences industry. Most recently he was chairman and managing director of sanofi-aventis in the UK, where he was also a member of sanofi-aventis' European executive committee. From 2008 to 2010 he was president of the UK's Association of the British Pharmaceutical Industry and served as a member of the Confederation of British Industry's presidents committee.

AVEO Pharmaceuticals has appointed Henri A Termeer, outgoing chairman, president and chief executive of Genzyme Corporation, to its board of directors. Termeer has served as president and a director of Genzyme Corporation since 1983, its chief executive officer since 1985 and as chairman since 1988. In addition, AVEO announced that directors Douglas Cole, a general partner at Flagship Ventures, and Russell Hirsch, managing director of Prospect Venture Partners, will not stand for re-election at AVEO's 2011 annual meeting in June.

Janet Hammond has joined Roche as vice-president of translational medicine – virology in pharmaceutical research and early development. She will be responsible for driving strategy and implementation of early clinical development for the Virology DTA. She has previously worked for Valeant Pharmaceuticals International, Bristol-Myers Squibb and GlaxoSmithKline.

Roche Diagnostics has appointed Robert Yates as head of Roche Applied Science. He succeeds Manfred Baier, who will be retiring at the end of 2011. Yates previously held increasing leadership positions in R&D, engineering and process management within Roche Diagnostics, in Indianapolis and in Roche´s headquarters in Basel. Most recently, he served as global head of business development and licensing.

Dr Christine Johnson and Dr David Paynton have been appointed as joint Clinical Leads for the Royal College General Practitioners Centre for Commissioning. They will provide clinical leadership to the centre, which aims to help GPs, practices and emerging GP consortia develop the skills, competences and expertise required to commission high quality health services, to improve patient care.

Neurotone has added Dr Raimund Eckel to its board of directors alongside Gerhard Musshafen and Dr Bruno Oesch. Meanwhile Dr Armin W Mäder is promoted to chief executive, taking over from Oesch who will focus more on business development.

Margot Rozga has joined OPEN Health as an associate partner. Rozga has worked in the pharmaceutical and communications industries for 15 years. Her responsibility will be to build the medical communications business with Sandy Royden.

ICON has promoted Kornelia Martin to vice-president of European operations. Martin will be responsible for driving ICON Medical Imaging's activities in Europe, which were expanded through the acquisition of Timaq Medical Imaging in May 2010. She joined ICON Medical Imaging in January 2009 as senior director of business development. Previously Martin held sales and scientific roles in Europe and the US for FOCUS Clinical Drug Development, Synarc and Baxter Oncology, Cellular Therapy.

ICON has also appointed Dr Malcolm Burgess as executive vice-president, Asia-Pacific. It has also selected Paula Mumby as vice-president, operations, Asia Pacific for its resourcing business unit DOCS.

Switzerland's Actelion has proposed that Jean-Pierre Garnier, the former GlaxoSmithKline chief executive officer, and Robert Bertolini, the former Schering-Plough finance chief, join its board, with a view to Garnier becoming chairman next year.

Sarah Phillips of Ipsos, Abigail Stuart of Hall and Partners and Kim Hughes of The Planning Shop International have been selected from a number of candidates to join the European Pharmaceutical Market Research Association (EphMRA) Board as Associate Members.

Ogilvy Healthworld Market Access has appointed Carsten Edwards as managing partner with effect from June 2011. Carsten will be responsible for working in partnership with the London and US based teams to deliver access programmes and initiatives that meet the ever-evolving market access needs of the industry. Carsten joins Ogilvy Healthworld Market Access from Chandler Chicco Companies where he held the position of managing director for Brandtectonics Access.

Related links